Petra Bismire is the Director of the Experimental Products Section which administers the patient access pathways for therapeutic goods not included in the ARTG, including the Special Access Scheme, Authorised Prescriber scheme and Clinical Trials schemes.

Petra’s regulatory experience also includes pre-market evaluation, pharmacovigilance inspection and periodic safety update report evaluation. Prior to her work as a regulatory scientist, Petra worked as a pharmacist in both hospital and community pharmacy settings in clinical roles.

‍